The phase three clinical trial reached a milestone with its first American participant receiving treatment, advancing ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

After becoming a patient himself following a recent cancer diagnosis, a local doctor said he wants to share his story to ...

People who are colorblind may be missing a life-saving warning sign of bladder cancer. Analysis of the electronic health ...

Can PSA derivatives reduce unnecessary prostate MRI after negative biopsy? Learn how simple markers may guide imaging ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...

September is Prostate Cancer Awareness Month, and health leaders are reminding men that early detection is the key to living ...

In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...

Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.

The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and ...